Quellen:
Pabon M, Cunningham J, Claggett B, Felker GM, McMurray JJV, Metra M, Diaz R, Wang X, Arias-Mendoza A, Bonderman D, Crespo-Leiro M, Fonseca C, Goncalvesova E, Lund M, O’Meara E, Sliwa-Hahnle K, Malik FI, Solomon SD, Teerlink JR; GALACTIC-HF Investigators. Sex Differences in Heart Failure With Reduced Ejection Fraction in the GALACTIC-HF Trial. JACC Heart Fail. 2023 Sep 25:S2213-1779(23)00521-8. doi: 10.1016/j.jchf.2023.07.029. Epub ahead of print. PMID: 37831045.
https://doi.org/10.1016/j.jchf.2023.07.029
Fonderico C, Pergola V, Faccenda D, Salucci A, Comparone G, Marrese A, Ammirati G, Cocchiara L, Varriale A, Esposito G, Rapacciuolo A, Strisciuglio T. Impact of sacubitril/valsartan and gliflozins on cardiac resynchronization therapy response in ischemic and non-ischemic heart failure patients. Int J Cardiol. 2023 Dec 15;393:131391. doi: 10.1016/j.ijcard.2023.131391. Epub 2023 Sep 23. PMID: 37748521.
https://doi.org/10.1016/j.ijcard.2023.131391